KEY FEATURES
| Full Name | Heterogeneous Nuclear Ribonucleoprotein A2/B1 |
|---|---|
| Synonym | hnRNP-A2/B1; hnRNPA2B1; RA33; HnRNPA2/B1 |
| Assay Type | Sandwich |
| Reactivity | Human |
| Range | 0.15-10ng/mL |
| Sensitivity | 0.06ng/mL |
| Sample Type | Serum,plasma and other biological fluids |
| Sample Volume | 100μL |
| Detection Wavelength | OD450 |
| Transportation Temperature | 2-8°C |
| Specificity | The kit detected Human HNRPA2B1 in the samples and no significant cross-species reactions were found |
| Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
| This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human HNRPA2B1. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human HNRPA2B1 and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human HNRPA2B1, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human HNRPA2B1. You can calculate the concentration of Human HNRPA2B1 in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
| Components | Specifications | Storage and Notes |
|---|---|---|
| Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
| Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
| Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
| HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
| Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
| Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
| Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
| Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Human HNRPA2B1 ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
| Intra-assay Precision | Inter-assay Precision | |||||
|---|---|---|---|---|---|---|
| Sample | 1 | 2 | 3 | 1 | 2 | 3 |
| n | 20 | 20 | 20 | 20 | 20 | 20 |
| Mean (ng/mL) | 0.5 | 1.07 | 4.3 | 0.45 | 1.06 | 4.16 |
| Standard deviation | 0.03 | 0.06 | 0.16 | 0.03 | 0.05 | 0.14 |
| CV(%) | 5.39 | 5.54 | 3.69 | 6.12 | 4.78 | 3.39 |
RECOVERY
The recovery of Human HNRPA2B1 spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
| Sample Type | Range (%) | Average Recovery (%) |
|---|---|---|
| Serum(n=8) | 90-105 | 96 |
| EDTA plasma (n=8) | 92-108 | 98 |
| Cell culture media (n=8) | 92-105 | 99 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Human HNRPA2B1 in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with HNRNPA2B1 ELISA Kits
| HNRNPC ELISA Kit | publications with HNRNPA2B1 and HNRNPC |
| SRSF1 ELISA Kit | publications with HNRNPA2B1 and SRSF1 |
| PCBP1 ELISA Kit | publications with HNRNPA2B1 and PCBP1 |
| HNRNPK ELISA Kit | publications with HNRNPA2B1 and HNRNPK |
| DHX9 ELISA Kit | publications with HNRNPA2B1 and DHX9 |
| SNRNP70 ELISA Kit | publications with HNRNPA2B1 and SNRNP70 |
| YBX1 ELISA Kit | publications with HNRNPA2B1 and YBX1 |
| HNRNPL ELISA Kit | publications with HNRNPA2B1 and HNRNPL |
Pathways associated with HNRNPA2B1 ELISA Kit
| Gene Expression Pathway | Gene Expression Pathway |
| Processing Of Capped Intron-Containing Pre-mRNA Pathway | Processing Of Capped Intron-Containing Pre-mRNA Pathway |
| MRNA Splicing Pathway | MRNA Splicing Pathway |
| MRNA Splicing - Major Pathway | MRNA Splicing - Major Pathway |
| MRNA Processing Pathway | MRNA Processing Pathway |
Diseases associated with HNRNPA2B1 ELISA Kit
| Nervous System Diseases | publications with HNRNPA2B1 and Nervous System Diseases |
| Lung Neoplasms | publications with HNRNPA2B1 and Lung Neoplasms |
| Brain Diseases | publications with HNRNPA2B1 and Brain Diseases |
| Disease Models, Animal | publications with HNRNPA2B1 and Disease Models, Animal |
| Atrophy | publications with HNRNPA2B1 and Atrophy |
| Cell Transformation, Neoplastic | publications with HNRNPA2B1 and Cell Transformation, Neoplastic |
| Cardiovascular Diseases | publications with HNRNPA2B1 and Cardiovascular Diseases |
| Liver Diseases | publications with HNRNPA2B1 and Liver Diseases |
| Breast Neoplasms | publications with HNRNPA2B1 and Breast Neoplasms |
| Liver Neoplasms | publications with HNRNPA2B1 and Liver Neoplasms |
Organs/Tissues associated with HNRNPA2B1 ELISA Kit
| Blood | publications with HNRNPA2B1 and Blood |
| Brain | publications with HNRNPA2B1 and Brain |
| Lung | publications with HNRNPA2B1 and Lung |
| Liver | publications with HNRNPA2B1 and Liver |
| Muscle | publications with HNRNPA2B1 and Muscle |
| Thymus | publications with HNRNPA2B1 and Thymus |
| Nerve | publications with HNRNPA2B1 and Nerve |
| Vascular | publications with HNRNPA2B1 and Vascular |
| Kidney | publications with HNRNPA2B1 and Kidney |
| Connective Tissue | publications with HNRNPA2B1 and Connective Tissue |